Sep 05, 2017 12:01 pm UTC| Business
BOSTON, Sept. 05, 2017 -- Keryx Biopharmaceuticals, Inc, (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced it will webcast corporate...
Atara Biotherapeutics Receives FDA Orphan Drug Designation for ATA230
Sep 05, 2017 12:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Sept. 05, 2017 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading "off-the-shelf" T-cell immunotherapy company developing novel treatments for patients with cancer and autoimmune...
Checkpoint Therapeutics to Present at the 19th Annual Rodman & Renshaw Global Investment Conference
Sep 05, 2017 12:01 pm UTC| Business
NEW YORK, Sept. 05, 2017 -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ:CKPT), a Fortress Biotech (NASDAQ:FBIO) company, today announced that James F. Oliviero, President and Chief Executive Officer of...
Cynata to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York
Sep 05, 2017 12:01 pm UTC| Business
MELBOURNE, Australia, Sept. 05, 2017 -- Australian stem cell and regenerative medicine company, Cynata Therapeutics Limited (ASX:CYP), announced today it will be featured as a presenting company at the 19th Annual...
Fortress Biotech to Present at the 19th Annual Rodman & Renshaw Global Investment Conference
Sep 05, 2017 12:01 pm UTC| Business
NEW YORK, Sept. 05, 2017 -- Fortress Biotech, Inc. (NASDAQ:FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today...
Biotricity FDA Submission Update
Sep 05, 2017 12:01 pm UTC| Business
REDWOOD CITY, Calif., Sept. 05, 2017 -- Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, is...
Sep 05, 2017 12:01 pm UTC| Business
BASKING RIDGE, N.J., Sept. 05, 2017 -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms targeting autoimmune and...